CAN FITE Fundamental Relationships

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:3em;padding-top: 35px;;'>CAN</div>
The Drivers Module shows relationships between CAN FITE's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of CAN FITE BIOPHARMA over time as well as its relative position and ranking within its peers. See also Trending Equities.

CAN FITE BIOPHARMA Market Capitalization vs. Gross Profit Fundamental Analysis

CAN FITE BIOPHARMA is number one stock in gross profit category among related companies. It is number one stock in market capitalization category among related companies creating about  895.29  of Market Capitalization per Gross Profit.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Gross Profit 
Cost of Revenue 
3.82 M
Gross Profit varies significantly from one sector to another and tells investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Market Capitalization is total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Market Cap 
Shares Outstanding 
Share Price 
3.42 B
In most publications or references market cap is broken down into the mega cap, large cap, mid cap, small cap, micro cap, and nano cap. Market Cap is a measurement of business as total market value of all of outstanding shares at a given time, and can be used to compare different companies based on their size.
CAN FITE BIOPHARMA is number one stock in market capitalization category among related companies. Market capitalization of Biotechnology industry is currently estimated at about 6.84 Billion. CAN FITE totals roughly 3.42 Billion in market capitalization claiming about 50% of stocks in Biotechnology industry.
Capitalization  Workforce  Total debt  Revenue  Valuation

CAN FITE Fundamental Comparison